Ridgewood Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,000
Closed -$48.4K 532
2025
Q2
$48.4K Buy
+5,000
New +$51.6K 0.02% 336
2024
Q1
Sell
-14,100
Closed -$203K 217
2023
Q4
$203K Sell
14,100
-20,978
-60% -$285K 0.12% 168
2023
Q3
$609K Sell
35,078
-2,621
-7% -$54.7K 0.4% 84
2023
Q2
$785K Buy
37,699
+1,439
+4% +$31.3K 0.45% 60
2023
Q1
$853K Buy
36,260
+1,069
+3% +$28.7K 0.52% 45
2022
Q4
$983K Buy
35,191
+3,950
+13% +$101K 0.7% 36
2022
Q3
$731K Buy
31,241
+3,593
+13% +$108K 0.61% 48
2022
Q2
$933K Buy
+27,648
New +$968K 0.73% 37
2022
Q1
Sell
-22,116
Closed -$673K 212
2021
Q4
$673K Buy
22,116
+2,852
+15% +$92.9K 0.43% 81
2021
Q3
$632K Buy
19,264
+2,956
+18% +$94.6K 0.43% 83
2021
Q2
$493K Buy
+16,308
New +$537K 0.32% 110

Other funds holding OGN

Ridgewood Investments's OGN Position: Q3 2025 in Review

Ridgewood Investments sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 5,000 shares — an estimated $48.4K sold.

Ridgewood Investments first reported a position in OGN in Q2 2021 and held it in 11 quarters. The position peaked at $983K in Q4 2022. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Ridgewood Investments reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • Ridgewood Investments sold 5,000 Organon & Co shares in Q3 2025, an estimated $48.4K.
  • Ridgewood Investments first reported a position in Organon & Co in Q2 2021 and held it in 11 quarters.
  • Ridgewood Investments's Organon & Co position peaked at $983K in Q4 2022.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Ridgewood Investments's 13F filing for Q3 2025, filed 30 Oct 2025.